| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |